ANAB

AnaptysBio Inc. Common Stock (ANAB)

Stock · NASDAQ · Health Care

$56.28as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$35.41
Industry
Biotechnology: Pharmaceutical Preparations

How AnaptysBio Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$234.60MOther$183.70M (78%)SG&A$50.74M (22%)Tax$164.0K (0%)ANAB

Source: 10-K filed Mar 3, 2026 · via SEC EDGAR / Finnhub

AnaptysBio Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ANAB
    AnaptysBio Inc. Common Stock
    $56.28
    ▼ 1.76%
    Market cap $1.59BP/E
  • AAPG
    Ascentage Pharma Group International American Depository Shares
    $18.28
    ▼ 2.16%
    Market cap $1.57BP/E
    $30$91.5
  • TRAX
    First Tracks Biotherapeutics Inc. Ordinary Shares
    $41.77
    ▼ 6.64%
    Market cap $1.61BP/E
    $14.72$49.91
  • INVA
    Innoviva Inc. Common Stock
    $20.97
    ▲ 0.05%
    Market cap $1.53BP/E 4.21
    $16.52$25.15
  • MRVI
    Maravai LifeSciences Holdings Inc. Class A Common Stock
    $7.67
    ▼ 8.42%
    Market cap $1.66BP/E
    $2.29$9.42
  • PAHC
    Phibro Animal Health Corporation Class A Common Stock
    $37.64
    ▲ 3.55%
    Market cap $1.51BP/E 14.51
    $28.25$60.08
  • BCAX
    Bicara Therapeutics Inc. Common Stock
    $23.42
    ▼ 5.70%
    Market cap $1.69BP/E
    $10.3$30.99

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
27.57M
Total value held
$1.50B
Institutional holders
199
Top holders this quarter
  • Unknown7.88M
  • Unknown1.68M
  • Unknown1.33M
  • Unknown993.9K
  • Unknown992.4K
  • Unknown940.0K
  • Unknown853.2K
  • Unknown821.9K
  • Unknown638.2K
  • Unknown625.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.